Host molecular targets not defined

The designation 'Host molecular targets not defined' is used in pharmacology to indicate that the specific biological molecules, such as receptors or enzymes, with which a drug interacts to produce its therapeutic effect are currently unknown. This situation is common in phenotypic drug discovery, where a compound is identified based on its ability to produce a desired biological outcome in a cell or organism without prior knowledge of its molecular target (Moffat et al., 2017, Nature Reviews Drug Discovery). While the drug may demonstrate clinical efficacy, the lack of a defined target limits the ability to perform structure-activity relationship (SAR) studies and rational drug design (Swinney & Anthony, 2011, Nature Reviews Drug Discovery). Identifying these targets is a crucial step in drug development to ensure safety, minimize off-target effects, and understand the drug's full pharmacological profile. Consequently, this term serves as a placeholder in databases and clinical documentation until the underlying molecular interactions are elucidated. It highlights a gap in the current understanding of a therapeutic agent's interaction with the host's biological systems, making it difficult to predict potential drug-drug interactions or long-term safety risks. Without a defined target, researchers cannot easily use biochemical assays to screen for potency or selectivity, often relying instead on complex and more variable cellular or animal models.

Other names

Unknown host targetUndisclosed targetTarget not identifiedPhenotypic target unknown

The mechanism of action is unknown as the specific molecular targets have not been identified.